Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice

Neuroscience Research

Volumn 51, Issue 1, 2005, Pages 111-115

  Mitsumoto, Yasuhide ^a   Mori, Atsushi ^a,b   Ohashi, Satoshi ^a   Nakai, Masami ^a   Moriizumi, Tetsuji ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine; Dopamine transporter; MPTP; Neurodegeneration; Olfactory bulb

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EXAMINATION; MALE; MOUSE; NERVE CELL LESION; NONHUMAN; OBSERVATION; OLFACTORY BULB; PARKINSONISM; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; NA(+)-K(+)-EXCHANGING ATPASE; NERVE TISSUE PROTEINS; OLFACTORY BULB; TYROSINE 3-MONOOXYGENASE;

EID: 10444257264     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.09.012     Document Type: Article

References (20)

1. E. Bezard, C.E. Gross, M.C. Fournier, S. Dovero, B. Bloch, and M. Jaber Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter Exp. Neurol. 155 1999 268 273
2. I. Brünig, M. Sommer, H. Hatt, and J. Bormann Dopamine receptor subtypes modulate olfactory bulb γ-aminobutyric acid type A receptors Proc. Natl. Acad. Sci. U.S.A. 96 1999 2456 2460
3. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
4. D.E. Dluzen 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice Brain Res. 586 1992 144 147
5. R.L. Doty, D.A. Deems, and S. Stellar Olfactory dysfunction in Parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration Neurology 38 1988 1237 1244
6. C.M. Gall, S.H. Hendry, K.B. Seroogy, E.G. Jones, and J.W. Haycock Evidence for coexistence of GABA and dopamine in neurons of the rat olfactory bulb J. Comp. Neurol. 266 1987 307 318
7. J.A. Javitch, R.J. D'Amato, S.M. Strittmatter, and S.H. Snyder Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proc. Natl. Acad. Sci. U.S.A. 82 1985 2173 2177
8. R. Lew, D. Grigoriadis, A. Wilson, J.W. Boja, S. Simantov, and M.J. Kuhar Dopamine transporter: deglycosylation with exo and endoglycosidases Brain Res. 539 1991 239 246
9. A.S. Mandir, S. Przedborski, V. Jackson-Lewis, Z.Q. Wang, C.M. Simbulan-Rosenthal, M.E. Smulson, B.E. Hoffman, D.B. Guastella, V.L. Dawson, and T.M. Dawson Poly (ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism Proc. Natl. Acad. Sci. U.S.A. 96 1999 5774 5779
10. R.A. Mayer, M.V. Kindt, and R.E. Heikkila Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport J. Neurochem. 47 1986 1073 1079
11. Y. Mitsumoto, A. Watanabe, A. Mori, and N. Koga Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice Biochem. Biophys. Res. Commun. 248 1998 660 663
12. T. Miwa, A. Watanabe, Y. Mitsumoto, M. Furukawa, N. Fukushima, and T. Moriizumi Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Acta Otolaryngol. 124 Suppl. 553 2004 80 84
13. U. Muthane, K.A. Ramsay, H. Jiang, V. Jackson-Lewis, D. Donaldson, S. Fernando, M. Ferreira, and S. Przedborski Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice Exp. Neurol. 126 1994 195 204
14. +) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum Exp. Neurol. 179 2003 103 110
15. + and mitochondrial function Life Sci. 40 1987 721 729
16. S. Przedborski, and V. Jackson-Lewis Models of Parkinson's disease Mov. Disord. 18 1998 729 737
17. N.M. Richtand, J.R. Kelsoe, D.S. Segal, and R. Kuczenski Regional quantification of dopamine transporter mRNA in rat brain using a ribonuclease protection assay Neurosci. Lett. 200 1995 73 76
18. + J. Neural Transm. 74 1988 147 150
19. K.F. Tipton, and T.P. Singer Advances in our understandein of the mechanisms of the neurotoxicity of MPTP and related compounds J. Neurochem. 61 1993 1191 1206
20. Z.K. Wszolek, and K. Markopoulou Olfactory dysfunction in Parkinson's disease Clin. Neurosci. 5 1998 94 101